Safety Evaluation of Intracoronary Infusion of Extracellular Vesicles in Patients With AMI

Status:
Recruiting

Trial end date:
2023-05-01

Target enrollment:

Participant gender:

Determine the safety of up to 3 dose levels of a study drug called PEP in patients who have had a recent (within the last 12 hours) heart attack.

Phase 1

Christopher J. McLeod
Paul G. Stalboerger

Rion LLC